Full Coverage

Sort

AbbVie's first quarter results

Top news

AbbVie Reports First-Quarter 2024 Financial Results - Apr 26, 2024

Apr 26

Morningstar

AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q

Apr 26

By Sabela Ojea

MarketWatch

MarketWatch

AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth

Apr 26

By Eleanor Laise

Seeking Alpha

AbbVie's Q1: Positive Surprise (NYSE:ABBV)

Apr 26

By Jonathan Weber

All coverage

Yahoo Finance

Yahoo Finance

Abbvie stock falls amid growing biosimilar competition

Apr 26

By Jared Blikre

AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod

Apr 26

By Zoey Becker

Crain's Chicago Business

AbbVie raises earnings forecast on strong immunology drug growth

Apr 26

MM+M Online

MM+M Online

AbbVie and Gilead post solid Q1 earnings, update full year outlooks

Apr 26

By Jack O'Brien

CNBC

CNBC

Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

8 days ago

By Annika Kim Constantino & Ashley Capoot

The Motley Fool

The Motley Fool

The Motley Fool

AbbVie (ABBV) Q1 2024 Earnings Call Transcript

Apr 26

TipRanks

TipRanks

AbbVie reports Q1 adjusted EPS $2.31, consensus $2.23 - TipRanks.com

Apr 26

Bloomberg

Bloomberg

AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses

Apr 26

By Madison Muller

AbbVie climbs after lifting 2024 profit forecast

Apr 26

As AbbVie Beats Expectations, Let's Check the Charts

Apr 26

By Bruce Kamich

AbbVie Raises Profit Forecast Amid Booming Drug Sales

Apr 27

By Carl Hazeley

Zacks Investment Research

AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates

Apr 26

BioSpace

BioSpace

AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq

Apr 26

By Tyler Patchen

StreetInsider.com

AbbVie (ABBV) hikes 2024 earnings guidance as Q1 beat estimates, shares up

Apr 26

By Vahid Karaahmetovic

Quartz

Quartz

AbbVie: Q1 Earnings Snapshot

Apr 26

The Pharma Letter

AbbVie reports better than expected 1st-qrt 2024 financials

Apr 26

The Business Journals

AbbVie looks to Skyrizi, other drugs to replace blockbuster Humira sales - Chicago Business Journal

Apr 26

Investing.com UK

Investing.com UK

Investing.com UK

AbbVie earnings beat by $0.04, revenue topped estimates By Investing.com

Apr 26

AbbVie First Quarter 2024 Earnings: Beats Expectations

Apr 27

Investor's Business Daily

Investor's Business Daily

Investor's Business Daily

AbbVie Stock: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales

Apr 29

By Allison Gatlin

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Apr 26

U.S News & World Report Money

Drugmaker AbbVie Expects Humira Volume Erosion to Worsen

Apr 26

By Leroy Leo, Christy Santhosh & Devika Syamnath

AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with Strong Growth in Key ...

Apr 27

Barron's

Barron's

AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop

Apr 26

By Angela Palumbo

WHBL

WHBL

AbbVie raises annual profit forecast on strong Skyrizi sales

Apr 26

MarketBeat

MarketBeat

AbbVie (NYSE:ABBV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Apr 26

Morningstar

AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises

Apr 26

Morningstar

AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure

Apr 26

By Damien Conover

Investopedia

Investopedia

AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump

Apr 26

By Bill McColl

Yahoo Finance

Yahoo Finance

AbbVie tries to reassure investors on Humira biosimilar threat

Apr 26

By Jonathan D. Gardner

Yahoo Finance

Yahoo Finance

Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Apr 30

Yahoo Finance

Yahoo Finance

AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say

Apr 26

Yahoo Finance

Yahoo Finance

AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View

Apr 26

Yahoo Finance

Yahoo Finance

Why AbbVie Stock Stumbled Today Despite the Earnings Beat

Apr 26

By James Brumley

Yahoo Finance

Yahoo Finance

AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript

Apr 30

By Insider Monkey

Yahoo Finance

Yahoo Finance

AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges

Apr 26

Quartz

Quartz

AbbVie raises full year profit guidance as Humira sales fall

Apr 26

By Bruce Gil

Investor's Business Daily

Investor's Business Daily

Investor's Business Daily

AbbVie Stock Dives Despite 'Firing On All Cylinders' In First Quarter

Apr 26

By Allison Gatlin

Yahoo Canada Finance

Drugmaker AbbVie expects Humira volume erosion to worsen

Apr 26

By Leroy Leo & Christy Santhosh

Yahoo Canada Finance

AbbVie First Quarter 2024 Earnings: Beats Expectations

Apr 28

Yahoo Canada Finance

Abbvie stock falls amid growing biosimilar competition

Apr 26

By Jared Blikre

The Motley Fool

The Motley Fool

The Motley Fool

AbbVie Beat on Q1 Earnings, Despite Challenges

Apr 29

Seeking Alpha

AbbVie: The Inevitable Is Happening (NYSE:ABBV)

Apr 29

Investing.com Canada

Investing.com Canada

Investing.com Canada

Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition

Apr 29

By Natashya Angelica

MSN

MSN

AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That

Apr 26

By Allison Gatlin

Abbvie stock falls amid growing biosimilar competition

Apr 26

By Jared Blikre

Abbvie stock falls amid growing biosimilar competition

Apr 26

By Jared Blikre

TipRanks

TipRanks

AbbVie (NYSE:ABBV) Sinks as Humira Drug Sees Increased Competition - TipRanks.com

Apr 26

By Vince Condarcuri

Seeking Alpha

AbbVie stock slides 6% amid concerns about falling Humira sales (NYSE:ABBV)

Apr 26

For you Top stories Local Following

Search

Clear search

Close search

Google apps

Main menu